2019 MedTech Predictions

By MedTech Intelligence Staff

Smart technologies will continue to play a big role in advancing decision-making efforts.

Jon Speer, Greenlight Guru
Jon Speer, founder and VP of QA/RA at Greenlight Guru

“I predict the next generation of wearables will significantly blur the lines between tech accessory and medical device. These “devices” will include capabilities such as measuring blood pressure, blood sugar, body temperature and more. The FDA is working closely with industry partners to identify common roadblocks to innovation. The De Novo Program, the classification Apple pursued for the Apple Watch, is the category for medical devices that don’t fall within an existing classification. As we blend medical technology with consumer technology, I foresee the De Novo program being utilized by companies such as Fitbit and Garmin. As a consumer, I’m very excited for the potential and advancements.” –  Jon Speer, Founder and VP of QA/RA, Greenlight Guru

“In 2019, medical devices, and software as a medical device, will come even closer to offering a human diagnosis than ever before. To date, most consumer-facing medical devices, like the Apple Watch, only provide general wellness advice and therefore are not regulated by the FDA or the EMA. With advancements in AI and machine learning, it’s easy to imagine the medical device of the future offering a human-like diagnosis, which of course means that software developers must increase their understanding of the complex regulations set forth by the FDA. While I never expect that medical devices will be able to replace doctors or nurses, they will have the capability to augment the work of both in 2019.” – Stephane Donze, CEO, AODocs


“There are three leading trends I see happening in 2019 for medical devices.

Abbas Dhilawala, Galen Data
Abbas Dhilawala, CTO, Galen Data

More remote monitoring: As hospitals try to reduce readmissions, more ways to monitor a patient in their home will be needed. Devices that provide that kind of remote monitoring capability will go mainstream in 2019.

In-home diagnostic kits: This started a few years back, but we see 2019 as a year where this will really take off. The ability for patients to do simple diagnostics tests like blood work, urine analysis, etc. will be widely available by 2019.

Clinical Decision Support Systems: Again, not a new concept, but we see more of these happening in 2019 that use artificial intelligence/machine learning to assist clinicians in making better decisions regarding the patients’ health and course of treatment.” – Abbas Dhilawala, CTO, Galen Data

Related Articles

  • Sanobar Syed

    Market research and forecasting help ensure that you are investing in a device or drug that is needed and will be well received. In this article, Sanobar Syed, Associate Director of Forecasting, Market Insights and Strategies, BeiGene, highlights strategies to…

  • Daniel Lace

    “We are honored to have Dr. Lace, who is widely recognized as one of the industry’s most trusted reimbursement experts, leading our new division. He will also support all our services as our CMO.”

  • Hand holding globe - diversity

    “Approaches to Increasing Diversity in Clinical Research and Addressing Health Inequities” offers key recommendations for device manufacturers and developers on steps they can take to increase diversity in clinical research and address health equity.

  • Amanda Bloom

    As VP of Product Marketing for a MedTech startup, my role is to champion pioneering medical technology, strategically spark interest and drive it out of the design lab and into the field where it will ultimately change, or even save…

About The Author

MedTech Intelligence